Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Neuhaus

Showing results (591-600 of 830) with videos related to

Pageof 83
Sort By:
Transplantation Proceedings|September 2, 1998
Cold ischemia affects sinusoidal endothelial cells while warm ischemia affects hepatocytes in liver transplantationM R Schön, O Kollmar, N Akkoc, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1988
Phase-II-study with EAP (etoposide, adriamycin, cis-platinum) in patients with primary inoperable gastric cancer and advanced diseaseP Preusser, H Wilke, W Achterrath, et al.
Transplantation Proceedings|August 15, 2002
Cyclosporine-based quadruple induction therapy versus tacrolimus-based dual immunosuppression after liver transplantation: ten-year follow-upS Jonas, O Guckelberger, A R Müller, et al.
Transplantation Proceedings|August 15, 2002
First results from a prospective randomized trial comparing steroid-free induction therapy with tacrolimus and MMF versus tacrolimus and steroids in patients after liver transplantation for HCVJ M Langrehr, U P Neumann, M Lang, et al.
Zeitschrift Fur Gastroenterologie|September 7, 2002
Combination prophylaxis with Hepatitis B immunoglobulin and lamivudine after liver transplantation minimizes HBV recurrence rates unless evolution of pretransplant lamivudine resistanceD Seehofer, N Rayes, T Steinmüller, et al.
Transplantation Proceedings|November 20, 1997
Early acute rejection episodes are reversible following retransplantation into a syngeneic donor and do not progress to chronic rejectionS G Tullius, M Nieminen, W O Bechstein, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1993
Aprotinin in orthotopic liver transplantationW O Bechstein, H Riess, G Blumhardt, et al.
Transplantation Proceedings|February 1, 1997
Effect of energy substrates on the preservation outcome of hepatocytes and sinusoidal endothelial cells in an experimental hypoxia/reoxygenation modelK Zeilinger, B Tonnelier, A Tschesche, et al.
Transplantation|September 27, 1996
GB virus C infection in patients with chronic hepatitis B and C before and after liver transplantationT Berg, U Naumann, T Fukumoto, et al.
Oncology|January 1, 1993
Position specificity of Ki-ras oncogene mutations during the progression of colorectal carcinomaC F Rochlitz, I Heide, E de Kant, et al.
Pageof 83

Showing results (591-600 of 830) with videos related to

Sort By:
Pageof 83
Transplantation Proceedings|September 2, 1998
Cold ischemia affects sinusoidal endothelial cells while warm ischemia affects hepatocytes in liver transplantationM R Schön, O Kollmar, N Akkoc, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1988
Phase-II-study with EAP (etoposide, adriamycin, cis-platinum) in patients with primary inoperable gastric cancer and advanced diseaseP Preusser, H Wilke, W Achterrath, et al.
Transplantation Proceedings|August 15, 2002
Cyclosporine-based quadruple induction therapy versus tacrolimus-based dual immunosuppression after liver transplantation: ten-year follow-upS Jonas, O Guckelberger, A R Müller, et al.
Transplantation Proceedings|August 15, 2002
First results from a prospective randomized trial comparing steroid-free induction therapy with tacrolimus and MMF versus tacrolimus and steroids in patients after liver transplantation for HCVJ M Langrehr, U P Neumann, M Lang, et al.
Zeitschrift Fur Gastroenterologie|September 7, 2002
Combination prophylaxis with Hepatitis B immunoglobulin and lamivudine after liver transplantation minimizes HBV recurrence rates unless evolution of pretransplant lamivudine resistanceD Seehofer, N Rayes, T Steinmüller, et al.
Transplantation Proceedings|November 20, 1997
Early acute rejection episodes are reversible following retransplantation into a syngeneic donor and do not progress to chronic rejectionS G Tullius, M Nieminen, W O Bechstein, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1993
Aprotinin in orthotopic liver transplantationW O Bechstein, H Riess, G Blumhardt, et al.
Transplantation Proceedings|February 1, 1997
Effect of energy substrates on the preservation outcome of hepatocytes and sinusoidal endothelial cells in an experimental hypoxia/reoxygenation modelK Zeilinger, B Tonnelier, A Tschesche, et al.
Transplantation|September 27, 1996
GB virus C infection in patients with chronic hepatitis B and C before and after liver transplantationT Berg, U Naumann, T Fukumoto, et al.
Oncology|January 1, 1993
Position specificity of Ki-ras oncogene mutations during the progression of colorectal carcinomaC F Rochlitz, I Heide, E de Kant, et al.
Pageof 83